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Spinal muscular atrophy (SMA) is a neurodegenera-
tive disease caused by a deficiency in the survival
motor neuron (SMN) protein. SMN mediates the
assembly of spliceosomal small nuclear ribonucleo-
proteins (snRNPs) and possibly other RNPs. Here,
we investigated SMN requirement for the biogenesis
and function of U7—an snRNP specialized in the
30-end formation of replication-dependent histone
mRNAs that normally are not polyadenylated. We
show that SMN deficiency impairs U7 snRNP assem-
bly and decreases U7 levels in mammalian cells. The
SMN-dependent U7 reduction affects endonucleo-
lytic cleavage of histone mRNAs leading to abnormal
accumulation of 30-extended and polyadenylated
transcripts followed by downstream changes in
histone gene expression. Importantly, SMN defi-
ciency induces defects of histone mRNA 30-end
formation in both SMA mice and human patients.
These findings demonstrate that SMN is essential
for U7 biogenesis and histone mRNA processing
in vivo and identify an additional RNA pathway dis-
rupted in SMA.
INTRODUCTION
Spinal muscular atrophy (SMA) is an inherited neurodegenera-
tive disease caused by reduced expression of the survival motor
neuron (SMN) protein due to homozygous mutation of the SMN1
gene (Burghes and Beattie, 2009). SMN is part of a macromolec-
ular complex that functions in the biogenesis of small nuclear
ribonucleoproteins (snRNPs) critical for pre-mRNA splicing
(Neuenkirchen et al., 2008; Pellizzoni, 2007). The SMN complex
mediates the assembly of a heptameric ring of Sm proteinsCell Re(B, D1, D2, D3, E, F, and G) onto spliceosomal small nuclear
RNAs (snRNAs) to build functional snRNPs (Meister et al.,
2001; Pellizzoni et al., 2002). Importantly, SMN deficiency de-
creases snRNP levels (Gabanella et al., 2007; Zhang et al.,
2008) and induces select splicing defects that contribute to
motor system dysfunction in animal models of SMA (Lotti
et al., 2012). The SMN complex is thought to have other roles
in RNA regulation that could also be relevant to SMA but are
poorly defined (Burghes and Beattie, 2009). Identification of
RNA pathways controlled by SMN, and characterization of asso-
ciated posttranscriptional gene regulatory events altered in
SMA, are critical to understanding mechanisms of motor neuron
disease.
Sm proteins, together with the structurally related Sm-like
(LSm) proteins, form a family of 20 ubiquitously expressed
and evolutionarily conserved RNA-binding proteins, paralogs
of which are found in all three branches of life (Tharun, 2009).
Evolutionary diversification allowed formation of Sm/LSm pro-
tein complexes of different composition that associate with
distinct RNAs and function in diverse RNA pathways such as
pre-mRNA splicing, histone mRNA 30-end processing, and cyto-
plasmic mRNA decay. Given both SMN’s essential role in Sm
core assembly and the structural similarities between Sm and
LSm cores, it is plausible that SMNmay participate in the assem-
bly of other Sm/LSm protein complexes onto their target RNAs.
To date, however, the only established target of SMN function
in vivo is spliceosomal snRNPs.
Here, we focused on U7 snRNP biogenesis and function to
establish a more general role for SMN in the RNP assembly of
the Sm/LSm protein family in vivo and to determine if this RNA
pathway is disrupted in SMA. U7 and spliceosomal snRNPs
follow an analogous biogenesis pathway but differ in both pro-
tein composition and function (Schu¨mperli and Pillai, 2004). U7
contains a unique mixed Sm/LSm core comprising Sm proteins
B, D3, E, F, G, and two LSm proteins (LSm10 and LSm11)
instead of the D1 and D2 of spliceosomal snRNPs (Pillai et al.,
2001, 2003). An SMN complex containing LSm10 and LSm11ports 5, 1187–1195, December 12, 2013 ª2013 The Authors 1187
Figure 1. SMN Is Required for U7 snRNP Biogenesis
(A) Western blot analysis of NIH 3T3-SmnRNAi and NIH 3T3-SMN/SmnRNAi cells
cultured with or without Dox for 5 days.
(B) In vitro U1 and U7 snRNP assembly with wild-type NIH 3T3 cell extracts. IP,
immunoprecipitation. mIgG, mouse immunoglobulin.
(C) In vitro U1 and U7 snRNP assembly with extracts from NIH 3T3-SmnRNAi
and NIH 3T3-SMN/SmnRNAi cells cultured with or without Dox for 5 days. IP,
immunoprecipitation.
(D) Quantification of U7 snRNP assembly from three independent experiments
as in (C).
(E) Northern blot analysis of NIH 3T3-SmnRNAi and NIH 3T3-SMN/SmnRNAi
cells cultured with or without Dox for 5 days.
(F) Quantification of U7 levels normalized to 5S rRNA from three independent
experiments as in (E).
(G) Schematic of the U7 gene and sequence of the U7 snRNA precursor. DSE,
distal sequence element; PSE, proximal sequence element.
Data in all graphs are represented as mean and SEM. See also Figure S1.
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(Pillai et al., 2003). However, it is unknown whether SMN is
required for U7 biogenesis and function in vivo. Unlike spliceoso-
mal snRNPs, U7 functions not in pre-mRNA splicing but in the
30-end processing of metazoan replication-dependent histone
mRNAs (Dominski and Marzluff, 2007). Histone transcripts of
this class contain no introns and are the only known eukaryotic
mRNAs that lack a poly(A) tail. Instead, these mRNAs end with
a conserved 30-end stem-loop (SL) structure generated by a
single U7-dependent endonucleolytic cleavage (Marzluff et al.,
2008). Proper histone mRNA 30-end processing is critical for
regulation of histone synthesis, which in turn is essential for
genome replication and function.
Using cellular and animal models, we demonstrate the essen-
tial role of SMN for the biogenesis of U7 snRNP and 30-end pro-
cessing of histone mRNAs in vivo. We also show that these
SMN-dependent RNA processing events are disrupted in tissues
from a mouse model of SMA as well as in human patients. Our
results expand the repertoire of RNA pathways regulated by
SMN and provide a molecular framework for exploring alter-
ations of U7 function and histone gene regulation in the etiology
of SMA.
RESULTS
SMN Is Required for U7 snRNP Biogenesis
To investigate SMN requirement for U7 snRNP assembly, we
utilized NIH 3T3-SmnRNAi cells in which addition of doxycycline
(Dox) causes depletion of endogenous mouse Smn (Figure 1A;
Lotti et al., 2012; Ruggiu et al., 2012). NIH 3T3-SMN/SmnRNAi
cells expressing RNAi-resistant human SMN were used to con-
trol for potential off-target effects of small hairpin RNA expres-
sion (Figure 1A). We also developed a monoclonal antibody
against LSm11 and confirmed its specificity by western blot as
well as selective immunoprecipitation of endogenous U7 snRNA,
but not spliceosomal U1 snRNA, from NIH 3T3 cell extracts (Fig-
ures S1A–S1C). To determine the specificity of U7 snRNP
assembly in our experimental conditions, in vitro transcribed
radioactive U1 and U7 snRNAs were incubated with NIH 3T3
cell extracts followed by immunoprecipitation with SmB and
LSm11 antibodies as well as mouse immunoglobulins. SmB
associated with both U1 and U7 whereas LSm11 associated
with U7 only (Figure 1B), demonstrating efficient and specific
formation of Sm cores in vitro. We then analyzed the effects of
SMN deficiency on U7 snRNP assembly using extracts from
NIH 3T3 cells with either normal or reduced SMN levels. These
experiments revealed a strong reduction of U7 snRNP assembly
in extracts from SMN-deficient NIH 3T3-SmnRNAi cells (Figures
1C and 1D), which was corrected proportionally to human
SMN expression in extracts from NIH 3T3-SMN/SmnRNAi cells
and similar to that of U1 snRNP (Figures 1C and 1D; Lotti
et al., 2012). Consistent with a previous study (Pillai et al.,
2003), these experiments demonstrate SMN requirement for
U7 snRNP assembly in vitro.
Next, we studied the effects of SMN deficiency on the accu-
mulation of U7 snRNP in NIH 3T3 cells. Northern blot showed
that SMN deficiency caused a strong reduction in U7 snRNA to
25% the amount in NIH 3T3-SmnRNAi cells with normal SMNhors
Figure 2. SMN Is Required for 30-End Formation of Histone mRNAs
(A) Schematic of the 30-end structure of histone mRNAs and position of qRT-
PCR primers.
(B) qRT-PCR analysis of 30-extended histone mRNAs in NIH 3T3-SmnRNAi and
NIH 3T3-SMN/SmnRNAi cells cultured with or without Dox for 5 days. RNA
levels in Dox-treated cells were expressed relative to untreated cells (dashed
line).
(C) Temporal analysis of SMN and U7 levels in NIH 3T3-SmnRNAi cells cultured
with Dox for the indicated number of days.
(D) qRT-PCR analysis of the time-dependent accumulation of 30-extended
histone mRNAs in NIH 3T3-SmnRNAi cells cultured as in (C). RNA levels in Dox-
treated cells were expressed relative to untreated cells (dashed line).
Data in all graphs are represented as mean and SEM.
Cell Reexpression and that this reduction was SMN-dependent as U7
levels were restored in NIH 3T3-SMN/SmnRNAi cells (Figures
1E and 1F). Furthermore, immunoprecipitation experiments
demonstrated a corresponding SMN-dependent decrease in
the levels of U7 snRNPs containing the Sm core and 50 tri-
methylated guanosine (TMG) cap (Figure S1D). Thus, SMN is
required for the accumulation of U7 snRNP in mammalian cells.
These experiments also revealed the association of SMN with
U7 snRNA in NIH 3T3 cells (Figure S1D), albeit to a lesser
extent compared to SmB or TMG antibodies, consistent with
U7 snRNA transient association with SMN while undergoing
Sm core assembly.
In addition to mature U7 snRNA, northern blot analysis re-
vealed a larger RNA species that increases in abundance upon
Smn deficiency (Figure 1E) and neither associates with Sm pro-
teins nor contains a TMG cap (Figure S1D). We isolated, cloned,
and sequenced this RNA from wild-type NIH 3T3 cells and iden-
tified it as a U7 snRNA precursor with an 35 nucleotide 30-end
extension predicted to form a hairpin structure (Figure 1G),
similar to that of spliceosomal pre-snRNAs (Yong et al., 2010).
This U7 pre-snRNA can function as a substrate for U7 snRNP
assembly in vitro (Figure S1E) and accumulates in SMN-deficient
NIH 3T3 cells (Figure 1E), consistent with the impairment of U7
snRNP biogenesis at a step preceding Sm core formation.
Furthermore, the presence of detectable levels of U7 pre-snRNA
under normal conditions suggests that SMN-mediated snRNP
assembly is a limiting step of U7 synthesis.
SMN Is Required for 30-End Formation of HistonemRNAs
U7 snRNP functions in the 30-end processing of replication-
dependent histone mRNAs (Schu¨mperli and Pillai, 2004). U7
binds the histone downstream element (HDE) and facilitates
recruitment of processing factors for endonucleolytic cleavage
of histone mRNAs between the 30 SL and the HDE (Dominski
and Marzluff, 2007). To investigate the effects of SMN-depen-
dent disruption of U7 snRNP biogenesis on histone mRNA
processing, we measured the levels of 30-extended histone tran-
scripts that may accumulate due to impaired cleavage (Fig-
ure 2A). Quantitative RT-PCR (qRT-PCR) revealed that SMN
deficiency caused a strong increase in unprocessed histone
mRNAs in NIH 3T3-SmnRNAi cells, which is corrected by human
SMN expression in NIH 3T3-SMN/SmnRNAi cells (Figure 2B). To
investigate the correlation among SMN protein depletion,
decreased U7 snRNA levels, and onset of histone mRNA pro-
cessing defects, we carried out a temporal analysis followingports 5, 1187–1195, December 12, 2013 ª2013 The Authors 1189
Figure 3. SMN Deficiency Alters Histone Gene Expression
(A) Schematic of histone mRNA 30-end processing events and position of qRT-PCR primers. ORF, open reading frame.
(B) qRT-PCR analysis of 30-extended histone mRNAs in poly(A)+ RNA from NIH 3T3-SmnRNAi cells cultured with or without Dox for 5 days. RNA levels in Dox-
treated cells were expressed relative to untreated cells.
(C) Schematic of the position of qRT-PCR primers for quantification of total histone mRNAs.
(D) qRT-PCR analysis of total histone mRNA levels in NIH 3T3-SmnRNAi cells cultured with or without Dox for 5 days. RNA levels in Dox-treated cells were
expressed relative to untreated cells.
(E) Analysis of protein synthesis by [35S]-methionine/cysteine pulse labeling in NIH 3T3-SmnRNAi and NIH 3T3-SMN/SmnRNAi cells cultured with or without Dox for
5 days.
(F) Western blot analysis of histones in NIH 3T3-SmnRNAi and NIH 3T3-SMN/SmnRNAi cells culturedwith or without Dox for 5 days. Total levels of core histones and
the linker histone H1 are measured as the antibodies do not distinguish the individual members of each multigene family.
Data in all graphs are represented as mean and SEM. See also Figure S2.RNAi induction in NIH 3T3-SmnRNAi cells (Figures 2C and 2D).
The earliest detectable defect of SMN deficiency was the accu-
mulation of U7 precursors beginning at day 2, which was then
followed at day 3 by a reduction in mature U7 levels and the
appearance of histone mRNA 30-end formation defects. Each
of these SMN-dependent events displayed a time-dependent
accumulation consistent with the progressive SMN depletion
and began prior to the onset of cell proliferation defects (Lotti
et al., 2012). These experiments indicate that SMN deficiency1190 Cell Reports 5, 1187–1195, December 12, 2013 ª2013 The Autimpairs the biogenesis of functional U7 snRNP leading to disrup-
tion of histone mRNA 30-end formation.
Replication-dependent histone transcripts that do not un-
dergo the proper 30-end cleavage are aberrantly extended
and subject to a downstream polyadenylation signal (Figure 3A;
Lanzotti et al., 2002; Narita et al., 2007). We investigated if
polyadenylated histone mRNAs accumulate in SMN-deficient
cells by qRT-PCR analysis of poly(A)+ mRNA isolated from
NIH 3T3-SmnRNAi cells with normal and reduced SMN. SMNhors
deficiency caused a remarkable accumulation of polyadeny-
lated replication-dependent histone mRNAs (Figure 3B) but
had no effects on replication-independent H3.3 and H2A.Z
histone mRNAs (Figure 3B), which are not processed by U7
and are normally polyadenylated (Marzluff et al., 2008). How-
ever, SMN deficiency increased the levels of polyadenylated
transcripts from the H2AX gene (Figure 3B). H2AX is an atypical
histone variant that contains a 30-end SL characteristic of repli-
cation-dependent histone mRNAs and undergoes 30-end cleav-
age in addition to being polyadenylated (Marzluff et al., 2008).
Thus, SMN-dependent defects in the 30-end formation of his-
tone mRNAs lead to the accumulation of their polyadenylated
mRNAs.
SMN Deficiency Disrupts Histone Gene Expression
Defective 30-end processing can lead to a reduction in themRNA
and protein levels of replication-dependent histones (Gruber
et al., 2012; Hsin et al., 2011; Sullivan et al., 2009). We therefore
investigated the consequences of SMN deficiency on histone
gene expression. qRT-PCR showed that the steady-state levels
of several histone mRNAs were altered in SMN-deficient NIH
3T3-SmnRNAi cells (Figures 3C and 3D). Analysis of pulse-labeled
proteins from both soluble and chromatin-bound fractions
indicated that SMN deficiency had no effects on global protein
synthesis, yet caused an 60% reduction in the synthesis of
core histones in NIH 3T3 cells; this reduction was corrected by
human SMN expression (Figure 3E). Further, western blot of
SMN-deficient NIH 3T3-SmnRNAi cells revealed a decrease in
the levels of the core histones and linker H1 protein (Figure 3F).
Consistent with defective 30-end formation and mRNA expres-
sion, the amount of the histone H2AX, but not H2AZ, was also
reduced. Collectively, these results indicate that SMN-depen-
dent disruption of histone 30-end formation can alter histone
gene expression.
SMN depletion induces cell proliferation defects in NIH 3T3
cells (Li et al., 2013; Lotti et al., 2012). We found that these
defects are associated with a decrease in the proportion of cells
in S phase and a corresponding increase of those in G1 (Fig-
ure S2A), akin to the effects of U7 snRNP inhibition on the cell
cycle (Wagner and Marzluff, 2006). Given the essential need for
histones in genome replication, the SMN-dependent impairment
of histone synthesis may contribute to these phenotypes. To
further investigate the effects of histone dysregulation induced
by SMN deficiency, we analyzed nucleosome repeat length in
SMN-deficient NIH 3T3 cells and found no evidence for gross
chromatin alterations (Figure S2B). We then focused on the his-
tone variant H2AX that has a well-established role in the cellular
response to genotoxic stress (Bonner et al., 2008). H2AX is
rapidly phosphorylated at serine 139 upon DNA damage, and
this phosphorylated form (gH2AX) acts as an initiating signal to
recruit various chromatin-remodeling complexes and DNA-
repair factors to the site of damaged DNA for efficient repair.
Consistent with the levels of H2AX expression, immunofluores-
cence experiments showed that gH2AX induction in NIH 3T3
cells treated with various DNA-damaging agents was reduced
by SMN deficiency (Figures S2C and S2D) and restored by
expression of human SMN (Figures S2E and S2F). Thus, disrup-
tion of histone gene expression induced by SMN deficiencyCell Remight impair cell division and the cellular ability to respond to
DNA damage.
SMN Deficiency Impairs U7 snRNP Biogenesis and
Histone 30-End Formation in SMA Mice
To investigate the effects of SMN deficiency on U7 snRNP
biogenesis and histone mRNA 30-end formation in vivo, we
used the SMND7 mouse model that has ubiquitously low levels
of SMN expression and manifests features of the human motor
neuron disease SMA (Le et al., 2005). First, we analyzed U7
snRNA levels in spinal cord, brain, and kidney from control
(Smn+/+;SMN2+/+;SMND7+/+), carrier (Smn+/;SMN2+/+;
SMND7+/+), and SMND7 SMA (Smn/;SMN2+/+;SMND7+/+)
mice at postnatal day 6 (P6), an early symptomatic stage in
this animal model. Northern blot showed a strong decrease in
U7 snRNA levels in all tissues from SMA mice when compared
to both control and carrier mice that are phenotypically normal
(Figures 4A and 4B). These results demonstrate an SMN require-
ment for U7 expression in vivo and its disruption in a mouse
model of SMA.
Next, we analyzed 30-end formation of histone mRNAs in SMA
mice. qRT-PCR revealed remarkable defects of histone mRNA
processing in the spinal cord as well as other tissues from
SMA mice compared to normal controls at P6 (Figures 4C,
S3A, and S3B). In the spinal cord of SMA mice, histone 30-end
formation defects are already present at a presymptomatic
stage, further accumulate in a time-dependent manner, and
are followed by alterations in the total levels of histone mRNAs
similar to those in SMN-deficient NIH 3T3 cells (Figures S3C
and S3D). Thus, SMN is required for histone 30-end formation
in vivo.
To study the effect of SMN deficiency on histone mRNA pro-
cessing in motor neurons, we injected fluorescently labeled
Alexa 488-conjugated cholera toxin subunit-b (CTb) into the
iliopsoas of both control and SMA mice at P2 and then selec-
tively isolated lumbar motor neurons innervating this axial mus-
cle by laser-capture microdissection at P6 (Lotti et al., 2012).
Remarkably, qRT-PCR demonstrated that SMN deficiency
impairs 30-end formation of histone mRNAs in SMA motor neu-
rons compared to normal motor neurons (Figure 4D), revealing
SMN-dependent disruption of this RNA pathway in disease-rele-
vant neurons of SMA mice.
Disruption of Histone 30-End Formation in SMA Patients
Given the requirement of SMN for histone mRNA processing
in vivo, we sought to investigate if defects in this pathway are
apparent in SMA patients. As expected, qRT-PCR showed
reduction in the levels of full-length SMN mRNA in both spinal
cord and psoas muscle from SMA patients compared to age-
matched controls (Figures S3E and S3G). Moreover, upregula-
tion of CDKN1A mRNA—a well-established event induced by
SMN deficiency in both SMA mice and human patients (Olaso
et al., 2006; Ruggiu et al., 2012)—was readily observed in human
SMA tissue whereas the levels of the ubiquitously expressed
ATP6 mRNA, used as additional control, did not change (Figures
S3E and S3G). Of key importance, qRT-PCR revealed the accu-
mulation of 30-extended histone mRNAs in both skeletal muscle
and spinal cord from SMA patients relative to controls (Figuresports 5, 1187–1195, December 12, 2013 ª2013 The Authors 1191
Figure 4. Disruption of U7 snRNP Biogenesis and Histone mRNA 30-End Formation in SMA
(A) Northern blot analysis of U7 expression in tissues from normal, carrier, and SMA mice at P6.
(B) Quantification of U7 levels normalized to 5S rRNA from three independent experiments as in (A).
(C) qRT-PCR analysis of 30-extended histone mRNAs in spinal cord from normal, carrier, and SMA mice at P6.
(D) qRT-PCR analysis of 30-extended histone mRNAs in LCM motor neurons from normal and SMA mice at P6.
(E) qRT-PCR analysis of 30-extended histone mRNAs in the spinal cord from controls (n = 3) and SMA patients (n = 4).
(F) qRT-PCR analysis of 30-extended histone mRNAs in the psoas from controls (n = 3) and SMA patients (n = 4).
Data in all graphs are represented as mean and SEM. See also Figure S3.4E and 4F). Although variable and more pronounced in psoas
muscle than in spinal cord, a consistent increase in the levels
of misprocessed histone mRNAs was found in tissue from all
SMA patients relative to controls (Figures S3F and S3H). Thus,
SMN deficiency of the magnitude of human SMA causes defects
in histone mRNA 30-end formation.1192 Cell Reports 5, 1187–1195, December 12, 2013 ª2013 The AutDISCUSSION
A key function of the SMN protein, mutation of which is respon-
sible for SMA, is as a molecular chaperone for the assembly
of RNP complexes involved in RNA processing. Knowledge of
the full repertoire of in vivo SMN functions is thus central forhors
understanding basic mechanisms of posttranscriptional gene
regulation and the basis for this motor neuron disease. Here,
we demonstrate that SMN is essential for U7 snRNP biogenesis
and proper 30-end processing of histone mRNAs in vivo. SMN
deficiency disrupts this fundamental RNA pathway in a mouse
model of SMA as well as human patients. These results conclu-
sively establish the in vivo requirement for SMN in the assembly
of Sm/LSm class RNPs beyond spliceosomal snRNPs and iden-
tify SMN-dependent RNA processing events affected in SMA.
These findings may have important implications in identifying
molecular mechanisms of this neurodegenerative disorder,
may open new avenues of therapeutic targeting, and may lead
to early disease biomarkers that are essential to efficient clinical
trials for SMN-restoring therapies.
Our studies establish SMN requirement for the biosynthesis of
functional U7 snRNP in vivo. We show that SMN associates with
U7 snRNAs and that formation of the Sm/LSm core on U7 is
strongly impaired by SMN deficiency, consistent with depletion
of a specialized SMN complex containing LSm10 and LSm11
proteins (Pillai et al., 2003). Importantly, we demonstrate that
the SMN-dependent disruption of U7 snRNP assembly leads
to a severe reduction in the levels of mature U7 and concomitant
accumulation of a previously uncharacterized U7 pre-snRNA.
The functional consequence of the U7 snRNP reduction induced
by SMN deficiency is the disruption of replication-dependent
histone mRNA processing as evidenced by accumulation of
uncleaved, 30-extended transcripts that are aberrantly polyade-
nylated. The production of polyadenylated histone mRNAs indi-
cates that the SMN-dependent reduction in functional U7 snRNP
levels does not result simply in slower processing of histone
transcripts but in a switch to a different modality of 30-end pro-
cessing. Whereas leaving open the possibility that SMN may
also influence the expression of other factors involved in histone
mRNA processing through its role in splicing with consequent
exacerbation of the effects of U7 reduction, loss of the unique
30-end structure of histone mRNAs through this series of RNA
processing defects induced by SMN deficiency ultimately leads
to dysregulated histone gene expression.
Complete loss of SMN function is incompatible with life at the
cellular and organism levels in mammals (Burghes and Beattie,
2009). Although this has been thought to result from disruption
of SMN function in RNA splicing, our findings provide an alterna-
tive, but not mutually exclusive, explanation. Because histones
are crucial for DNA replication, defective histone synthesis
induced by U7 deficiency in the absence of SMN would likely
halt cell division at an early stage and contribute to embryonic
lethality. Accordingly, severe cell-proliferation defects ensue in
response to U7 dysfunction (Ideue et al., 2009; Wagner andMar-
zluff, 2006) and SMN depletion (Lotti et al., 2012) in mammalian
cells.
Our results demonstrate that U7 snRNP biogenesis and func-
tion are disrupted in SMA—a childhood neurodegenerative dis-
ease characterized by ubiquitous SMN deficiency (Burghes
and Beattie, 2009). The observation that histone mRNA 30-end
processing defects accumulate in multiple tissues of both SMA
mice and human patients points to this RNA pathway as a candi-
date source for biomarkers in SMA. Biomarkers are greatly
needed to serve as molecular readouts for the efficacy of a vari-Cell Reety of therapeutics currently entering SMA clinical trials (Van
Meerbeke and Sumner, 2011). Additionally, both U7 reduction
and histone 30-end formation defects can be used in preclinical
studies to evaluate restoration of SMN function in SMA mice.
Our discovery that SMN deficiency alters histone mRNA pro-
cessing in SMA has potential important implications for under-
standing the molecular mechanisms of the disease. Whereas
motor neuron loss is a hallmark of SMA, it is becoming increas-
ingly clear that other networked neurons participate in motor
system dysfunction induced by SMN deficiency (Imlach et al.,
2012; Mentis et al., 2011) and other cell types inside and outside
the nervous system may also contribute to SMA pathology
(Hamilton and Gillingwater, 2013). In addition to RNA-splicing
defects (Lotti et al., 2012; Ruggiu et al., 2012; Zhang et al.,
2008), altered histone gene regulation induced by SMN defi-
ciency could potentially have profound cellular consequences
and contribute to some of these deficits. Reduced cell prolifera-
tion in the hippocampus of SMA mice causing defects in brain
development (Wishart et al., 2010) may be the downstream
consequence of defects in histone synthesis. The effects of
SMN-dependent histone dysregulation need not be limited to
impaired proliferation, however. Consistent with increased sus-
ceptibility to genotoxic stress of SMA patient-derived fibroblasts
(Wang et al., 2005), we show that SMN deficiency can lead to
decreased expression of histone H2AX and lower levels of its
phosphorylated form upon DNA damage. Importantly, we also
show that SMN deficiency causes disruption of histone mRNA
30-end formation in SMA motor neurons, demonstrating that
SMN-dependent histone dysregulation is not restricted to
cycling cells. Histones play essential roles in the regulation of
gene expression by facilitating dynamic changes in the structural
and functional organization of chromatin. Even subtle alterations
in the cellular pool of histones could have significant effects on
gene regulation and detrimental consequences in SMA neurons.
In summary, our findings identify an RNA pathway that is dis-
rupted by SMN deficiency in vivo in experimental models and
human disease tissues and provide the initial foundation for a
potential involvement of histone dysregulation in the etiology of
SMA. Future studies will determine whether SMN-dependent
U7 snRNP dysfunction and histone 30-end formation defects
have a role in SMA pathology. In light of our findings and
emerging connections between SMN and genes associated
with amyotrophic lateral sclerosis (Yamazaki et al., 2012), inves-
tigation of amore general role for histone biology in humanmotor
neuron disease will also deserve consideration.EXPERIMENTAL PROCEDURES
NIH 3T3 Cell Lines
The NIH 3T3 cell lines used in this study have been described previously (Lotti
et al., 2012; Ruggiu et al., 2012). Treatments and methods for extract prepara-
tion and immunoprecipitation are described in the Supplemental Experimental
Procedures.
SMA Mice and LCM
All experiments with mice were conducted as approved by the Institutional
Laboratory Animal Care and Use Committee of Columbia University.
FVB.Cg-Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb Smn1tm1Msd/J
(JAX Stock number 005025) mice were interbred to obtain SMA mutant miceports 5, 1187–1195, December 12, 2013 ª2013 The Authors 1193
(Le et al., 2005). CTb was injected in the iliopsoas muscle of normal and SMA
mice at P2, and motor neurons were isolated by laser capture microdissection
(LCM) from spinal cords of injected mice at P6 (Lotti et al., 2012).
Human SMA Tissue
SMA and control human tissue was collected at autopsy following parental
informed consent as approved by the Johns Hopkins Medicine Institutional
ReviewBoard. Some control human tissuewas also obtained from theNational
Institute of Child Health and Human Development Brain and Tissue Bank for
Developmental Disorders at theUniversity ofMaryland, Baltimore, MD. Further
information is provided in the Supplemental Experimental Procedures.
RNA Analysis
Total RNA was isolated using Trizol reagent (Invitrogen) followed by digestion
with RNase-free DNaseI (Ambion). Poly (A)+ RNA was purified from total RNA
using oligo(dT)+ beads (New England Biolabs). RNA from LCM neurons was
purified using the Absolutely RNA Nanoprep Kit (Agilent Technologies), and
linear amplification was performed with the MessageAmp II aRNA Amplifica-
tion Kit (Ambion) according to the manufacturer’s instructions. qRT-PCR
and northern blot experiments were carried out as previously described (Lotti
et al., 2012). The sequence of primers and probes used in this study are listed
in Table S1. In vitro snRNP assembly experiments were carried out as
described previously with minor modifications (Gabanella et al., 2007; Pelliz-
zoni et al., 2002). Additional information is provided in the Supplemental Exper-
imental Procedures.
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